NEXT GENERATION RADIOLIGANDS
Mark Identification

NEXT GENERATION RADIOLIGANDS

Serial Number

97664916

Filing Date

Nov 6, 2022

Trademark by

POINT BIOPHARMA INC.

Classification Information

Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Pharmaceuticals